Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Combination of Lenvatinib and Pembrolizumab Is an Effective Treatment Option for Anaplastic and Poorly Differentiated Thyroid Carcinoma
PaperCitations, authors & open-access status
Combination of Lenvatinib and Pembrolizumab Is an Effective Treatment Option for Anaplastic and Poorly Differentiated Thyroid Carcinoma is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 251 citations, 2021 year and hybrid oa status.
251
Citations
2021
Year
hybrid
OA Status